This grant funds community programs to prevent drug overdose deaths by increasing access to FDA-approved opioid overdose reversal medications.
Funder: Substance Abuse and Mental Health Services Administration
Due Dates (Anticipated): July 2026 (Full application deadline, projected)
Funding Amounts: Estimated total program funding: $11,050,000; ~13 anticipated awards; no cost sharing required.
Summary: Supports community-wide programs to prevent drug overdose deaths by expanding access to FDA-approved opioid overdose reversal medications.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
This grant opportunity aims to support the development and implementation of comprehensive, community-wide programs designed to prevent drug overdose deaths. The primary focus is on expanding access to FDA-approved opioid overdose reversal medications, enabling communities to respond more effectively to the ongoing opioid crisis. The program seeks to fund domestic public and private nonprofit entities, including faith-based organizations, to build sustainable prevention and response strategies.